Statement Of Cash Flows [Abstract]

Biocartis Group NV - Filing #3123157

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities	—	6,429,000 EUR	—	7,172,000 EUR	—
Income taxes paid (refund), classified as operating activities	—	2,000 EUR	—	3,000 EUR	—
Cash flows from (used in) operating activities	—	65,716,000 EUR	—	39,267,000 EUR	—
Cash flows from (used in) investing activities [abstract]
Other cash payments to acquire interests in joint ventures, classified as investing activities	—	0 EUR	—	1,000,000 EUR	—
Purchase of property, plant and equipment, classified as investing activities	—	3,686,000 EUR	—	3,005,000 EUR	—
Purchase of intangible assets, classified as investing activities	—	69,000 EUR	—	15,000 EUR	—
Interest received, classified as investing activities	—	7,000 EUR	—	13,000 EUR	—
Cash flows from (used in) investing activities	—	3,748,000 EUR	—	4,007,000 EUR	—
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities	—	6,000,000 EUR	—	0 EUR	—
Repayments of borrowings, classified as financing activities	—	7,089,000 EUR	—	7,167,000 EUR	—
Other inflows (outflows) of cash, classified as financing activities	—	115,000 EUR	—	50,000 EUR	—
Cash flows from (used in) financing activities	—	1,204,000 EUR	—	11,523,000 EUR	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	70,668,000 EUR	—	54,797,000 EUR	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	522,000 EUR	—	260,000 EUR	—
Cash and cash equivalents	53,522,000 EUR	—	123,668,000 EUR	—	178,725,000 EUR